Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN

Kahn Swick & Foti, LLC announced an investigation into whether Geron Corporation's officers and directors breached fiduciary duties to shareholders or otherwise violated state or federal laws. The probe stems from a February 26, 2025 disclosure that growth of Rytelo, Geron's telomerase inhibitor imetelstat, had flattened due to seasonality, competition, low awareness, and treatment monitoring burden; a securities class action against the company and certain executives remains ongoing.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.